QRON Projected Dividend Yield
Qrons Inc ( OTCBB : QRON )Qrons is a preclinical stage biotechnology company developing stem cell synthetic hydrogel-based solutions to combat neuronal injuries in the treatment of traumatic brain injuries (TBIs), for both concussions and penetrating injuries. Co. has two products candidates for treating penetrating and non-penetrating (concussion-like) TBIs, both integrating proprietary, anti-brain inflammation synthetic hydrogel and engineered mesenchymal stem cells (MSCs). QS100™ is an injury specific, 3D printable, implantable MSCs-synthetic hydrogel, to treat penetrating brain injuries and QS200™ is an injectable MSCs-synthetic hydrogel for the treatment of diffused injuries commonly referred to as concussions. 20 YEAR PERFORMANCE RESULTS |
QRON Dividend History Detail QRON Dividend News QRON Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |